Triplatin Tetranitrate

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameTriplatin Tetranitrate
Drug Alias NameBBR-3464
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlkylating agentsDNA inhibitors
TargetsDNA
Therapy Area/IndicationsLung NeoplasmsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTheradex
Active IndicationsN/A
Inactive IndicationsLung NeoplasmsPancreatic Neoplasms

Other Information

ATC CodeN/A
Related LinksWikipedia